Erik Esveld

Erik Esveld appears in our data through filings on BioInvent International AB shares, published by Finansinspektionen. We count 3 filings; the first trade dates from 1 September 2023 and the latest from 23 February 2024.

On the market, this insider has only ever bought: 3 purchases, €27k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2024 alone, the filings show 2 purchases and no sales.

The median purchase comes to €7,565. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 23 February 2024, reports an open-market purchase of €7,565 in BioInvent International AB. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.